Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Bharath Rangarajan"'
Autor:
Arun Seshachalam, Shashidhar V. Karpurmath, Krishnakumar Rathnam, S. Ganapathi Raman, Murugesan Janarthinakani, Krishna Prasad, Channappa Patil, Parameswaran Anoop, Neelesh Reddy, Satish Kumar Anumula, Sirigeri Prabhakar Roopa, Krishna Reddy Golamari, Madhav Danthala, Prasad Gunari, Basawantrao Malipatil, Bharath Rangarajan, Karthik S. Udupa, Manjunath Nandennavar, Kesavan Niraimathi, Hemant Deepak Shewade
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-13 (2019)
PURPOSE: Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) improves overall survival (OS) in patients with Hodgkin lymphoma (HL) relative to ABVD (doxorubicin, bleomycin, vinblastine, a
Externí odkaz:
https://doaj.org/article/75c65104a38844c4896d2f8746351f77
Publikováno v:
Medical Journal of Dr. D.Y. Patil University, Vol 10, Iss 6, Pp 585-588 (2017)
Melanoma of mucosal sites is rare and is extremely rare in esophagus. Melanoma is known for its histological diversity mimicking any other malignancies with poor prognosis. Clinical presentation may be similar to other gastroesophageal junction malig
Externí odkaz:
https://doaj.org/article/989aa800b8c247c587a2b9885e44a496
Autor:
Ram Abhinav Kannan, Bharath Rangarajan
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 130-131 (2020)
Externí odkaz:
https://doaj.org/article/f7f7db17edd145c784e99fe8ef571499
Autor:
Bharath Rangarajan, Tanuja Shet, Tabassum Wadasadawala, Nita S Nair, R Madhu Sairam, Sachin S Hingmire, Jyoti Bajpai
Publikováno v:
South Asian Journal of Cancer, Vol 5, Iss 3, Pp 86-92 (2016)
The Incidence of breast cancer has been steadily increasing in the last two decades, more so in urban areas of the sub-continent. Cancer ceters across the country have large numbers of patients being treated with multiple publications in this field.
Externí odkaz:
https://doaj.org/article/4492c36bc13443768c83246d4ea9ab2b
Autor:
Bharath Rangarajan, Ram K Abhinav
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 224-225 (2019)
Externí odkaz:
https://doaj.org/article/a8b6966e07114620bad76debd5e1640a
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 265-265 (2019)
Externí odkaz:
https://doaj.org/article/9b461c41db374412b673f865e4d634fa
Publikováno v:
South Asian Journal of Cancer, Vol 3, Iss 3, Pp 182-184 (2014)
Hyponatremia is a common and often under-recogonised clinical problem in oncologic practice. The recogonition of the cause of hyponatremia and initiation of appropriate and timely intervention can prevent morbidity and improve treatment tolerance. Th
Externí odkaz:
https://doaj.org/article/7d0c262f31c6477094e499ff41dd6ca6
Publikováno v:
South Asian Journal of Cancer, Vol 2, Iss 3, Pp 108-108 (2013)
Externí odkaz:
https://doaj.org/article/53dd4d74d7664b6f915bd845d015a5ab
Autor:
Basawantrao Malipatil, Krishna Prasad, K. Niraimathi, Bharath Rangarajan, Sirigeri Prabhakar Roopa, Murugesan Janarthinakani, Parameswaran Anoop, Julius Xavier Scott, Karthik S Udupa, Arun Seshachalam, Madhav Danthala, Saravanan Raman, Satish Kumar Anumula, Krishna Reddy Golamari, Krishnakumar Rathnam, Shashidhar V. Karpurmath, Arathi Srinivasan, Manjunath Nandennavar, Neelesh Reddy, Channappa N Patil
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 42:415-425
Introduction Most Indian centers use Adriamycin/Bleomycin/Vinblastine/Dacarba-zine (ABVD) chemotherapy for pediatric Hodgkin lymphoma (pHL). To reduce the late toxicity, robust predictive markers are needed to risk stratify pHL patients, thereby limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a520b4be241532fd9d9e9d24e5b5316f
https://doi.org/10.1055/s-0041-1730240
https://doi.org/10.1055/s-0041-1730240
Autor:
K. Niraimathi, Channappa N Patil, Satish Kumar Anumula, Prasad Gunari, Karthik S Udupa, Neelesh Reddy, S. Ganapathi Raman, Shashidhar V. Karpurmath, Murugesan Janarthinakani, Parameswaran Anoop, Manjunath Nandennavar, Arun Seshachalam, Bharath Rangarajan, Krishnakumar Rathnam, Sirigeri Prabhakar Roopa, Basawantrao Malipatil, Krishna Prasad, Krishna Reddy Golamari, Madhav Danthala, Hemant Deepak Shewade
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-13 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) improves overall survival (OS) in patients with Hodgkin lymphoma (HL) relative to ABVD (doxorubicin, bleomycin, vinblastine, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d32f4ec16bed06a1c4ab6919ff369c
https://doi.org/10.1200/jgo.19.00179
https://doi.org/10.1200/jgo.19.00179